Citations

Clear

3042 citation(s) found for "Kumar, S".

Amyloid-Beta-Related Angiitis with Distinctive Neuro-Ophthalmologic Features
Dumitrașcu, Oana , Okazaki, Erin, Cobb, Steven H., Zarka, Matthew A., Souza, Stephen De , Kumar, Gyanendra , O’Carroll, Cumara B. , Dumitrascu, Oana M , Okazaki, Erin M

Mayo Clinic

Neuro-Ophthalmology | September 19, 2017 | Volume: 42 | Issue: 4 | Pages: 237-241

10.1080/01658107.2017.1374982 | PMID 30042795 Get It

Role of Admission Troponin‐T and Serial Troponin‐T Testing in Predicting Outcomes in Severe Sepsis and Septic Shock
Vallabhajosyula, Saraschandra , Sakhuja, Ankit , Geske, Jeffrey B. , Poterucha, Joseph T., Jaffe, Allan S. , Vallabhajosyula, Saraschandra , Geske, Jeffrey B , Kumar, Mukesh , Kashyap, Rahul , Kashani, Kianoush , Jaffe, Allan S. , Jentzer, Jacob C.

Mayo Clinic

Journal of the American Heart Association | September 9, 2017 | Volume: 6 | Issue: 9 | Pages: No page available

10.1161/jaha.117.005930 | PMID 28889100 Get It

Background Troponin‐T elevation is seen commonly in sepsis and septic shock patients admitted to the intensive care unit. We sought to evaluate the role of admission and serial troponin‐T testing in the prognostication of these patients. Methods and Results This was a retrospective cohort study from 2007 to 2014 on patients admitted to the intensive care units at the Mayo Clinic with severe sepsis and septic shock. Elevated admission troponin‐T and significant delta troponin‐T were defined as ≥0.01 ng/mL and ≥0.03 ng/mL in 3 hours, respectively. The primary outcome was in‐hospital mortality. Secondary outcomes included 1‐year mortality and lengths of stay. During this 8‐year period, 944 patients met the inclusion criteria with 845 (90%) having an admission troponin‐T ≥0.01 ng/mL. Serial troponin‐T values were available in 732 (78%) patients. Elevated admission troponin‐T was associated with older age, higher baseline comorbidity, and severity of illness, whereas significant delta troponin‐T was associated with higher severity of illness. Admission log 10 troponin‐T was associated with unadjusted in‐hospital (odds ratio 1.6; P =0.003) and 1‐year mortality (odds ratio 1.3; P =0.04), but did not correlate with length of stay. Elevated delta troponin‐T and log 10 delta troponin‐T were not significantly associated with any of the primary or secondary outcomes. Admission log 10 troponin‐T remained an independent predictor of in‐hospital mortality (odds ratio 1.4; P =0.04) and 1‐year survival (hazard ratio 1.3; P =0.008). Conclusions In patients with sepsis and septic shock, elevated admission troponin‐T was associated with higher short‐ and long‐term mortality. Routine serial troponin‐T testing did not add incremental prognostic value in these patients.
Checking in: T cells against multiple myeloma
Kumar, Shaji , Kumar, Shaji K

Mayo Clinic

Blood | September 7, 2017 | Volume: 130 | Issue: 10 | Pages: 1175-1176

10.1182/blood-2017-05-783647 | PMID 28882832 Get It

Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation
Shantha, Ghanshyam Palamaner Subash , Inampudi, Chakradhari , Kumar, Anita , Chaikriangkrai, Kongkiat , Bhise, Viraj , Deshmukh, Abhishek , Patel, Nileshkumar , Horwitz, Phillip A. , Mickelsen, Steven , Bhave, Prashant D. , Oral, Hakan , Vaughan‐Sarrazin, Mary , Mentias, Amgad , Pancholy, Samir , GIUDICI, MICHAEL C. , Vaughan Sarrazin, Mary

Mayo Clinic

Journal of the American Heart Association | September 1, 2017 | Volume: 6 | Issue: 8 | Pages: No page available

10.1161/jaha.117.006381 | PMID 28862952 Get It

Background Sex‐specific effectiveness of rivaroxaban ( RIVA ), dabigatran ( DABI ), and warfarin in reducing myocardial infarction ( MI ), heart failure ( HF ), and all‐cause mortality among patients with atrial fibrillation are not known. We assessed sex‐specific associations of RIVA , DABI , or warfarin use with the risk of MI , HF , and all‐cause mortality among patients with atrial fibrillation. Methods and Results Medicare beneficiaries (men: 65 734 [44.8%], women: 81 135 [55.2%]) with atrial fibrillation who initiated oral anticoagulants formed the study cohort. Inpatient admissions for MI , HF , and all‐cause mortality were compared between the 3 drugs separately for men and women using 3‐way propensity‐matched samples. In men, RIVA use was associated with a reduced risk of MI admissions compared with warfarin use (hazard ratio [95% confidence interval ( CI ): 0.59 [0.38–0.91]), with a trend towards reduced risk compared with DABI use (0.67 [0.44–1.01]). In women, there were no significant differences in the risk of MI admissions across all 3 anticoagulants. In both sexes, RIVA use and DABI use were associated with reduced risk of HF admissions (men: RIVA ; 0.75 [0.63–0.89], DABI ; 0.81 [0.69–0.96]) (women: RIVA ; 0.64 [0.56–0.74], DABI ; 0.73 [0.63–0.83]) and all‐cause mortality (men: RIVA ; 0.66 [0.53–0.81], DABI ; 0.75 [0.61–0.93]) (women: RIVA ; 0.76 [0.63–0.91], DABI ; 0.77 [0.64–0.93]) compared with warfarin use. Conclusions RIVA use and DABI use when compared with warfarin use was associated with a reduced risk of HF admissions and all‐cause mortality in both sexes. However, reduced risk of MI admissions noted with RIVA use appears to be limited to men.
Mobilization and Transplantation Patterns of Autologous Hematopoietic Stem Cells in Multiple Myeloma and Non-Hodgkin Lymphoma
Costa, Luciano J. , Kumar, Shaji , Stowell, Stephanie A., Dermer, Shari, Costa, Luciano J

Mayo Clinic

Cancer Control | August 30, 2017 | Volume: 22 | Issue: 1 | Pages: 87-94

10.1177/107327481502200111 | PMID 25504282 Get It

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
Moreau, Philippe , Chanan‐Khan, Asher , Roberts, Andrew W. , Agarwal, Amit B., Kumar, Shaji , Touzeau, Cyrille , Punnoose, Elizabeth A. , Cordero, Jaclyn, Munasinghe, Wijith, Jia, Jia , Salem, Ahmed Hamed , Freise, Kevin J. , Enschede, Sari H., Maciag, Paulo , Verdugo, Maria, Roberts, Andrew W , Moreau, Philippe , Touzeau, Cyrille , Facon, Thierry T.F. , Leverson, Joel D. , Ross, Jeremy A. , Harrison, Simon J , Salem, Ahmed Hamed

Mayo Clinic

Blood | August 29, 2017 | Volume: 130 | Issue: 22 | Pages: 2392-2400

10.1182/blood-2017-06-788323 | PMID 28847998 Get It

Key Points In relapsed/refractory MM, venetoclax plus bortezomib and dexamethasone appears to be safe and efficacious. This is a novel therapeutic approach for MM.
Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe Obesity
Iqbal, Anoop , Dahl, Amanda , Lteif, Aida, Kumar, Seema , Iqbal, Anoop Mohamed, Dahl, Amanda R, Kumar, Seema

Mayo Clinic

Children | August 28, 2017 | Volume: 4 | Issue: 9 | Pages: 80

10.3390/children4090080 | PMID 28846662 Get It

Severe obesity is associated with abnormal lipids and increased risk for cardiovascular disease. Obesity is a risk factor for vitamin D deficiency. We examined relationship between 25-hydroxy vitamin D (25(OH)D) concentrations and lipids in children with severe obesity. Medical records of 376 children were reviewed. Linear regression models and logistic regression were used to examine the relationship between 25(OH)D and lipids after adjustment for age, gender, season of blood draw, body mass index (BMI) z-score, and BMI % of 95th percentile. Two-hundred sixty-three out of 376 children (70%) had 25(OH)D concentrations < 30 ng/mL. Concentrations of 25(OH)D were positively correlated with those of high-density lipoprotein cholesterol (HDL-C) (r2 = 0.08, r = 0.22, β = 0.16, 95% CI = 0.05–0.27, p = 0.004). HDL-C was lower in children with 25(OH)D < 30 ng/mL (n = 263) compared to those with 25(OH)D ≥ 30 ng/mL (n = 113) (41.3 ± 10.2 vs. 46.4 ± 12 mg/dL, p < 0.0001). Children with 25(OH)D concentrations < 30 ng/mL had greater adjusted odds of low HDL-C (<40 mg/dL) compared with those with 25(OH)D ≥ 30 ng/mL (47.9% vs. 29.2%, OR 2.15 (1.33–3.51), p = 0.0019). Total cholesterol and non-HDL-C were not correlated with 25(OH)D concentrations. Vitamin D deficiency is highly prevalent in children with severe obesity. Prospective clinical trials are warranted to determine if vitamin D supplementation can improve HDL-C and potentially decrease risk for cardiovascular disease in children with obesity.
Papilloedema and Autoimmune Retinopathy from Systemic Lupus Erythematosus
Chen, John J. , Kumar, Neeraj , McEvoy, Kathleen M., Leavitt, Jacqueline A., Chen, John J

Mayo Clinic

Neuro-Ophthalmology | August 18, 2017 | Volume: 42 | Issue: 2 | Pages: 117-121

10.1080/01658107.2017.1355395 | PMID 29563958 Get It

Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis
Hwa, Yi L. , Warsame, Rahma , Gertz, Morie A. , Buadi, Francis K. , Lacy, Martha Q. , Kumar, Shaji , Dingli, David , Zeldenrust, Steve R., Hayman, Susanne R., Kapoor, Prashant , Kourelis, Taxiarchis , Russell, Stephen J. , Hobbs, Miriam, Fonder, Amie , Dispenzieri, Angela , Gertz, Morie A , Buadi, Francis K , Russell, Stephen J , Dingli, David , Zeldenrust, Steven R., Leung, Nelson , Gonsalves, Wilson I. , Go, Ronald S. , Rajkumar, S. Vincent , Dispenzieri, Angela

Mayo Clinic

Blood | August 14, 2017 | Volume: 130 | Issue: 13 | Pages: 1578-1584

10.1182/blood-2017-05-783415 | PMID 28807981 Get It

Key Points Organ progression at second-line therapy predicated inferior survival. Patients relapsing from >VGPR had a longer time to develop organ progression.